Toxicologic investigations on a new anti-arrhythmic compound: 1,5-dimorpholino-3-(l-naphthyl)-pentane (DA 1686).
D000410:Alanine Transaminase / Q000032:analysis / Q000037:antagonists & inhibitors; D000618:Aminohippuric Acids / Q000652:urine; D000681:Amylases / Q000037:antagonists & inhibitors; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000097:blood / Q000633:toxicity* / Q000652:urine; D001219:Aspartate Aminotransferases / Q000032:analysis / Q000037:antagonists & inhibitors; D001798:Blood Proteins / Q000032:analysis; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D003404:Creatinine / Q000032:analysis; D005260:Female; D005919:Glomerular Filtration Rate; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008297:Male; D009025:Morpholines / Q000633:toxicity*; D009281:Naphthalenes / Q000633:toxicity*; D009929:Organ Size; D010179:Pancreas / Q000201:enzymology; D010434:Pepsin A / Q000037:antagonists & inhibitors; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors; D011817:Rabbits; D051381:Rats
D000618:Aminohippuric Acids; D000889:Anti-Arrhythmia Agents; D001798:Blood Proteins; D002800:Cholinesterase Inhibitors; D009025:Morpholines; D009281:Naphthalenes; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D010744:Phosphoric Monoester Hydrolases; D000681:Amylases; D010434:Pepsin A